Study Group: Byetta Prescribers for Diabetes: Endocrinologists (US)(?)
Council Members in this Study Group: 117
Request a survey with this Study Group
Leading Experts in this Study Group
Division Head of Endocrinology and Metabolism
Evanston Northwestern Healthcare
Joseph Bass, MD, PhD, is Assistant Professor of Medicine and Neurobiology at Northwestern University in Illinois and Division Head of Endocrinology and Metabolism at Evanston Northwestern Healthcare. He is also the Director of a federally-funded basic research program on obesity, diabetes, and lipid...
Harold Bays, MD, FACPPresident and Medical Director
L-MARC Research Center
Harold Bays, MD, FACE, FACP, is Medical Director and President of Louisville Metabolic and Atherosclerosis Research Center (L-MARC), a metabolic clinical research facility that has conducted over 400 phase I-IV clinical trials, including studies of all marketed lipid-altering drug treatments, as well...
Clinical Professor of Medicine
University of California, Los Angeles
Dan Streja, MD, is a Clinical Professor of Medicine at the University of California, Los Angeles. He is Co-Director of the Lipid Clinic, the Cardiovascular Prevention Clinic and Diabetes Clinic, and the Divisions of Cardiology and Endocrinology at VA Medical Center of West Los Angeles. Dr. Streja has...
Michael DempseyMedical Director
Johns Hopkins Diabetes Center at Suburban Hospital
Michael Dempsey, MD, is a Private Practitioner in Rockville, Maryland. He is the Medical Director of the Johns Hopkins Diabetes Center at Suburban Hospital, where he is also the Medical Director of Diabetes Education and Endocrine Subsection Chair. He is the Vice-President of the Mid-Atlantic chapter...
Director of General Internal Medicine
Saint Louis University
George Griffing, MD, is Director of General Internal Medicine at St. Louis University. Dr. Griffing’s clinical expertise includes the diagnosis and treatment of diabetes. His research interests include the clinical investigation of inhaled insulin, nasal insulin and pramlintide. Dr. Griffing is a...
Related Study Groups
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Most hospitals are financially built on their heart programs. The "agressive" medical arm is conservative by our standards yet as good as stents at far less cost. If this was truly pursued by large companies with TPA insurance plans, their overall cost would drop with large savings in healthcare costs....
The ACCORD trial results were no suprise to our diabetes practice. We have been heavy users of Byetta since launch in 2005, and have seen the same results in our population of > 2000 diabetics with over 700 on Byetta. Since the Simpson et al study in the Canadian Journal of Medicine (CMAJ 2006;174(2):169-74)...
The recent finding that Byetta therapy decreased mortality in the ACCORD study needs to be replicated in studies designed to address that point. Even if it is replicated and statistically significant, it probably will not be true for the widely anticipated once weekly extended formulation...
Therapeutic effects of drugs are seen essentially in all treated patients. Adverse outcomes are infrequent. The July 1-2 FDA diabetes panel recommendation that sturdy systems for determining outcome should be required for all new diabetes treatments may lead to a >100-fold increase in...
As exciting as the DURATION I study results have been, Roche's GLP-1 agonist is also looking good in earlier phase trials, and there are MANY competitors in this GLP-1 realm, as well as the gliptins (oral, with similar efficacy on glucose and A1c but without the dramatic weight loss), chomping at the...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Government/Military Hospital or Clinic
- Private/For-Profit Healthcare Research Entity
Most Common Job Types:
- Physician - Attending Physician
- Physician - Director
- Owner
- Physician - Division Head
- President
- Partner
- Director
- Physician - Department Chair
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

